Dual-Drug Stent a Reality

Conor Medsystems Inc. (Menlo Park, CA) announced that the first patient has been treated with its stent that can deliver two drugs at once. In a release available on devicelink.com, the company said it has begun a trial comparing stents that elude pimecrolimus with stents that elude both pimecrolimus and paclitaxel. The former is an anti-inflammatory and the latter is an anti-proliferative.